Unibest Industrial Co., Ltd.

We caring about the future. Unibest is driven by green chemistry and environment-friendly technology to build a safe and healthy world.#Greenchemistry

📢 #DrugPatentWatch: Week of Nov 4, 2024 This week's focus is on notable medications approaching their patent and exclusivity thresholds: 💊 Sprycel by Bristol Myers Squibb Co, containing active ingredient Dasatinib; for treating Philadelphia chromosome-positive chronic myeloid leukemia and acute lymphoblastic leukemia. 💊 Prevymis (solution; tablets; pellets) by Merck Sharp and Dohme, containing active ingredient Letermovir; for preventing disease caused by cytomegalovirus in people who have received a bone marrow transplant or kidney transplant. 💊 Exem Foam Kit by Giskit Pharma BV, containing active ingredient Air Polymer-Type A; as a foam that can be used with transvaginal ultrasound to assess tubal patency in women with infertility. 💊 Zelboraf by Hoffmann La Roche Inc, containing active ingredient Vemurafenib; for preventing disease caused by cytomegalovirus in people who have received a bone marrow transplant or kidney transplant. 💊 Alecensa by Hoffmann-La Roche Inc, containing active ingredient Alectinib Hydrochloride; for treating certain types of NSCLC with an abnormal ALK gene. 💊 Byetta by AstraZeneca AB, containing active ingredient Exenatide Synthetic; for controlling blood sugar levels. 💊 Symbicort by AstraZeneca LP, containing active ingredients Budesonide and Formoterol Fumarate Dihydrate; for controlling and preventing symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease. 💊 Tobi Podhaler by Mylan Specialty LP, containing active ingredient Tobramycin; for treating people with cystic fibrosis who have an ongoing lung infection with P.aerugionsa. 💊 Omegaven by Fresenius Kabi USA LLC, containing active ingredient 💊 Fish Oil Triglycerides; as an oil-based ib lipid emulsion that is a source of calories and fatty acids in pediatric patients with PNAC. 💊 Xiidra by Bausch and Lomb Inc., containing active ingredient Lifitegrast; for reducing both symptoms and signs of dry eye disease. As these drugs approach patent expiration, new opportunities arise for generic development and market entry. At Unibest, we're poised to support pharmaceutical companies in navigating these opportunities with our comprehensive R&D, CDMO, and manufacturing services. For a more detailed analysis and to explore how these changes might impact your business, visit our blog: https://lnkd.in/gmaNC8zt #Pharmaceuticals #GenericDrugs #DrugDevelopment #CDMO #Unibest

📢 #DrugPatentWatch: Week of Oct 28, 2024 At Unibest, we're committed to keeping our partners informed about upcoming opportunities in the pharmaceutical industry. Our weekly patent expiration watch helps you stay ahead of the curve. This week, we're monitoring these significant drugs approaching patent and exclusivity milestones: 💊 Adasuve by Alexza Pharmaceuticals, containing active ingredient Loxapine 💊 Brilinta by AstraZeneca, containing active ingredient Ticagrelor 💊 Defencath by CorMedix, containing active ingredients Heparin Sodium and Taurolidine 💊 Vuity by AbbVie, containing active ingredient Pilocarpine Hydrochloride 💊 Aubagio by Sanofi, containing active ingredient Teriflunomide 💊 Calquence by AstraZeneca, containing active ingredient Acalabrutinib As these drugs approach patent expiration, new opportunities arise for generic development and market entry. At Unibest, we're poised to support pharmaceutical companies in navigating these opportunities with our comprehensive R&D, CDMO, and manufacturing services. For a more detailed analysis and to explore how these changes might impact your business, visit our blog: https://lnkd.in/ef2c2aw2 #Pharmaceuticals #GenericDrugs #DrugDevelopment #CDMO #Unibest

📢 #DrugPatentWatch: This Week's Expiration Report At Unibest, we're committed to keeping our partners informed about upcoming opportunities in the pharmaceutical industry. Our weekly patent expiration watch helps you stay ahead of the curve. This week, we're monitoring these significant drugs approaching patent and exclusivity milestones: 💊 ABRAXANE by Bristol Myers Squibb; containing Paclitaxel 💊 TRIKAFTA by Vertex Pharmaceuticals; containing Elexacaftor, Ivacaftor, and Tezacaftor 💊 XIPERE by Bausch + Lomb; containing Triamcinolone Acetonide As these drugs approach patent expiration, new opportunities arise for generic development and market entry. At Unibest, we're poised to support pharmaceutical companies in navigating these opportunities with our comprehensive R&D, CDMO, and manufacturing services. For a more detailed analysis and to explore how these changes might impact your business, visit our blog: https://lnkd.in/gtqDs7Ex #Pharmaceuticals #GenericDrugs #DrugDevelopment #CDMO #Unibest

Explore the power of flow chemistry in the synthesis of critical pharmaceuticals like Belzutifan. This exemplar case study, conducted by external researchers, showcases the environmental and efficiency benefits that #Unibest is committed to implementing. Discover this flow chemistry practice and how we're driving towards greener solutions in the pharma industry. 👉https://lnkd.in/eJNceAgb #greenchemistry #pharmaceuticals

Next week, the Unibest Business Development team led by Teresa Chu is eager to make an impact at the upcoming CPhI Japan 2024, taking place April 17-19. 🙂 Join us as we pursue partnerships that combine traditional methods with advanced technology for a more sustainable pharmaceutical industry. 💡 Get the inside scoop! What's new at the Unibest BD department? We've been prioritizing green chemistry and have recently delved into AI-guided enzyme engineering for use in pharmaceutical R&D and manufacturing. This approach reduces costs, sets new efficiency and innovation standards, and promotes environmental protection. By providing a comprehensive suite for the global market, we aim to make a significant impact. We invite you to meet our business development team and discover how our integrated solution can support your success. To schedule a meeting, please use this link: https://lnkd.in/gjk4mmuy. We look forward to connecting with you at CPhI Japan 2024. #CPhIJapan2024 #Unibest #BusinessDevelopment #SustainablePharma #GreenChemistry #AI #EnzymeEngineering #Innovation

After a brief pause, we are excited to rejuvenate our CDMO showcase with an overview of the world of radiopharmaceuticals. Last year in 2023, we witnessed a unique molecule with the FDA approval of Flotufolastat F-18 (Posluma, developed by Blue Earth Diagnostics), marking a significant advancement in diagnostic radiopharma. Chelators are essential components of radiopharmaceuticals, especially for those radioisotopes that are not covalently bound. They coordinate with and stabilize the metal radioisotopes so that the radiations can be emitted at a desired site, which is guided by a ligand. This allows for the creation of Radionuclide Drug Conjugates (RDCs). Check out our Newly Synthesized Chelators 🔬 CAS RN. 170908-81-3, DOTA-NHS ester 👉 https://lnkd.in/gsvk4a-M 🔬 CAS RN. 127985-74-4, DOTA derivative 👉 https://lnkd.in/g9MimbTt 🔬 CAS RN. 58966-93-1, NOTA intermediate 👉 https://lnkd.in/gh3rhsfK Looking forward to connecting and venturing into new frontiers of healthcare advancement together! Stay tuned for more updates, and feel free to reach out for collaborations or inquiries. #Radiopharmaceuticals #Chelators #UnibestCDMO

🐉 As we look forward to the Year of the Dragon, we invite you all to read our latest (the last one in this Year of the Rabbit) blog [https://lnkd.in/gJdaGG6S] on CGRP migraine drug market status—may it bring you a headache-free new year! 🤞 #Unibest #YearOfTheDragon #CGRP #drugmaket #MigraineFree

🎊🐉 Happy Chinese New Year from #Unibest! 🐉🎊 As we prepare to welcome the Year of the Dragon, our team is excited to celebrate this venerable festivity with our loved ones. We want to inform all our industrial partners, clients, and friends that our offices will be closed for the Chinese New Year holiday from February 9th to February 17th, and we will have limited access to emails and calls. As we say in Chinese, 新年快乐 (Xīnnián kuàilè) - Happy New Year! May the new lunar year bless you with health, wealth, and happiness. Our normal business operations will resume on February 18th, 2024. Thank you for your understanding and support. ✨ #ChineseNewYear #YearOfTheDragon

💡 Ever wondered about the magic bullet in organic chemistry synthesis? Much like how targeted therapy idealizes the concept of a "magic bullet" in medicine, the same analogy can be applied in synthesis! Introducing, Molecular building blocks - the LEGO pieces of organic chemistry synthesis.🧱 As a guide to drug design, molecular building blocks mimicking endogenous cellular molecules are ingeniously used and designed to navigate drug discovery. Interested in learning more about how this magic happens? 💊Read the full article at [https://lnkd.in/gc2qczD7]. #pharmaceuticals #organicchemistry #drugdesign #innovation